Mumbai Worksite Tobacco Control Study
1 other identifier
interventional
6,880
1 country
1
Brief Summary
The investigators are designing and testing the effectiveness of an integrated tobacco control and occupational health (OH) intervention aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies in 20 manufacturing worksites in the greater Mumbai region of India.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 19, 2013
CompletedFirst Posted
Study publicly available on registry
April 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2016
CompletedApril 17, 2017
April 1, 2017
6.1 years
March 19, 2013
April 14, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Tobacco use cessation
6-month post intervention
Secondary Outcomes (1)
Changes in company tobacco policy
6-month post intervention
Study Arms (2)
Intervention Program
EXPERIMENTALReceives the full Healthy, Safe, and Tobacco-Free Worksites intervention
Delayed Intervention Control
OTHERReceives abbreviated 2-month delayed intervention designed to provide employees with knowledge and skills to quit tobacco after final data collection time point, as well as one non-tobacco event in between data collection points.
Interventions
Receives an integrated tobacco control and occupational health (OH) intervention (The Healthy, Safe, and Tobacco-Free Worksites program) aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies. Through six health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use. Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.
Receives abbreviated 2-month delayed intervention designed to provide employees with knowledge and skills to quit tobacco after final data collection time point, as well as one non-tobacco event in between data collection points.
Eligibility Criteria
You may qualify if:
- Manufacturing worksites located in the Mumbai, Thane, or Raigad districts of India
- Employ at least 60% production workers/40% administrative staff OR at employ at least 200 production workers on staff. NOTE: We are defining "workers" as anyone who is on the company roster, regardless of whether they're permanent or contractual
- Companies must be autonomous decision-makers and allow us to function at their worksite
- Companies must be willing to provide us with a current employee roster
You may not qualify if:
- Employees do not speak English, Hindi, or Marathi
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Harvard School of Public Health (HSPH)lead
- National Cancer Institute (NCI)collaborator
- Healis-Sekhsaria Institute for Public Healthcollaborator
- Carelon Researchcollaborator
- Dana-Farber Cancer Institutecollaborator
Study Sites (1)
Healis-Sekhsaria Institute for Public Health
Navi Mumbai, Maharshtra, India
Related Publications (1)
Sorensen G, Pednekar M, Cordeira LS, Pawar P, Nagler EM, Stoddard AM, Kim HY, Gupta PC. Effects of a worksite tobacco control intervention in India: the Mumbai worksite tobacco control study, a cluster-randomised trial. Tob Control. 2017 Mar;26(2):210-216. doi: 10.1136/tobaccocontrol-2015-052671. Epub 2016 Feb 16.
PMID: 26883793DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Glorian Sorensen, PhD, MPH
Harvard School of Public Health, Dana-Farber Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Society, Human Development, and Health
Study Record Dates
First Submitted
March 19, 2013
First Posted
April 29, 2013
Study Start
June 1, 2010
Primary Completion
June 30, 2016
Study Completion
June 30, 2016
Last Updated
April 17, 2017
Record last verified: 2017-04